
Research view
Title: | Clinical profile of cannabis-induced psychosis in comparison to schizophrenia |
Author: | Doha El-Serafi and Doaa Hewedi |
Abstract: |
Background
The question whether substance-induced psychotic disorders can be differentiated
from schizophrenia on the basis of clinical and psychological tests performance
remains inconclusive. We hypothesize that cannabis-induced psychosis and
schizophrenia have different cognitive, premorbid, and clinical features.
Objective
The main objective of this study was to investigate and describe clinical profile of
cannabis-induced psychosis and to plot a comparative study between patients with
cannabis-induced psychosis and schizophrenic with regard to cognitive abilities, different
personality traits as well as phenomenological differences between both groups.
Patients and methods
This was a cross-sectional comparative study in which 60 patients were recruited; 30
patients with diagnosed cannabis-induced psychosis and 30 patients with diagnosed
schizophrenia. The patients were selected from inpatient units and outpatient psychiatric
clinics at the Institute of Psychiatry, Ain Shams University, over a period of 6 months. The
recruited samples were assessed by a semistructured interview on the basis of the
interview (questionnaire) sheet of the Institute of Psychiatry, Ain Shams University
Hospital, and the diagnosis was made on the basis of ICD-10 symptom checklist. They
were also assessed by the following scales: Wechsler Intelligence Scale, Minnesota
Multiphasic Personality Inventory, and Positive and Negative Symptoms Scale.
Results
We found that cannabis-induced psychosis patients have statistically significant better
cognitive functioning in the object assembly, less lie and correction, more
psychopathic deviation, more antisocial and borderline traits, and less negative and
general psychopathology symptoms compared with schizophrenic patients.
Conclusion
Results from the present study support previous evidence that tasks of cognitive
functions, personality assessment, and clinical evaluation distinguish cannabisinduced
psychosis and schizophrenia even in the earliest stages of illness and that the
two disorders can be differentiated on the basis of areas of selective deficit. However,
the present results also support the hypothesis of a continuum of illness severity, in
which significant deficits are evident in all diagnostic groups, but with different severity.
Keywords:
cannabis induced psychosis, cognitive functions, clinical symptoms, personality,
schizophrenia
|
Journal: | Middle East Current Psychiatry 2014, 21:230–236 |
Text: | |
Download Link |